- 現金殖利率: 2.48%、總殖利率: 7.13%、5年平均現金配發率: 39.56%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 3.20 | 6.67 | 1.50 | 0.0 | 0.50 | 66.67 | 46.88 | -6.25 | 15.62 | 56.25 | 62.50 | 4.17 |
2022 (9) | 3.00 | -6.83 | 1.50 | -11.76 | 0.30 | 0 | 50.00 | -5.29 | 10.00 | 0 | 60.00 | 13.65 |
2021 (8) | 3.22 | 37.61 | 1.70 | 750.0 | 0.00 | 0 | 52.80 | 517.7 | 0.00 | 0 | 52.80 | 23.54 |
2020 (7) | 2.34 | 0 | 0.20 | 0 | 0.80 | 0 | 8.55 | 0 | 34.19 | 0 | 42.74 | 0 |
2019 (6) | -0.82 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2018 (5) | 0.30 | 400.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2017 (4) | 0.06 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2016 (3) | -4.55 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
23Q4 (20) | 0.91 | 295.65 | -25.41 | 0.88 | 633.33 | -23.48 | 3.21 | 39.57 | 6.64 |
23Q3 (19) | 0.23 | -57.41 | -69.33 | 0.12 | -78.18 | -86.81 | 2.30 | 7.98 | 28.49 |
23Q2 (18) | 0.54 | -66.25 | 775.0 | 0.55 | -64.52 | 358.33 | 2.13 | 33.12 | 104.81 |
23Q1 (17) | 1.60 | 31.15 | 42.86 | 1.55 | 34.78 | 31.36 | 1.60 | -46.84 | 42.86 |
22Q4 (16) | 1.22 | 62.67 | -3.94 | 1.15 | 26.37 | 0.0 | 3.01 | 68.16 | -6.81 |
22Q3 (15) | 0.75 | 1037.5 | -5.06 | 0.91 | 658.33 | 133.33 | 1.79 | 72.12 | -8.67 |
22Q2 (14) | -0.08 | -107.14 | -900.0 | 0.12 | -89.83 | 233.33 | 1.04 | -7.14 | -17.46 |
22Q1 (13) | 1.12 | -11.81 | -10.4 | 1.18 | 2.61 | 5.36 | 1.12 | -65.33 | -10.4 |
21Q4 (12) | 1.27 | 60.76 | -13.01 | 1.15 | 194.87 | -7.26 | 3.23 | 64.8 | 37.45 |
21Q3 (11) | 0.79 | 7800.0 | -32.48 | 0.39 | 533.33 | -32.76 | 1.96 | 55.56 | 120.22 |
21Q2 (10) | 0.01 | -99.2 | -98.75 | -0.09 | -108.04 | -112.33 | 1.26 | 0.8 | 550.0 |
21Q1 (9) | 1.25 | -14.38 | 214.68 | 1.12 | -9.68 | 227.27 | 1.25 | -46.81 | 214.68 |
20Q4 (8) | 1.46 | 24.79 | 244.55 | 1.24 | 113.79 | 125.45 | 2.35 | 164.04 | 386.59 |
20Q3 (7) | 1.17 | 46.25 | 715.79 | 0.58 | -20.55 | 2033.33 | 0.89 | 417.86 | 368.42 |
20Q2 (6) | 0.80 | 173.39 | 1900.0 | 0.73 | 182.95 | 204.17 | -0.28 | 74.31 | -175.68 |
20Q1 (5) | -1.09 | -7.92 | -430.3 | -0.88 | -260.0 | -366.67 | -1.09 | -32.93 | -430.3 |
19Q4 (4) | -1.01 | -431.58 | 0.0 | 0.55 | 1933.33 | 0.0 | -0.82 | -531.58 | 0.0 |
19Q3 (3) | -0.19 | -575.0 | 0.0 | -0.03 | -112.5 | 0.0 | 0.19 | -48.65 | 0.0 |
19Q2 (2) | 0.04 | -87.88 | 0.0 | 0.24 | -27.27 | 0.0 | 0.37 | 12.12 | 0.0 |
19Q1 (1) | 0.33 | 0.0 | 0.0 | 0.33 | 0.0 | 0.0 | 0.33 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/3 | 1.38 | -23.8 | -12.62 | 4.97 | -14.05 | 4.97 | N/A | - | ||
2024/2 | 1.82 | 2.54 | 24.44 | 3.59 | -14.59 | 5.63 | N/A | - | ||
2024/1 | 1.77 | -13.19 | -35.37 | 1.77 | -35.37 | 5.62 | N/A | - | ||
2023/12 | 2.04 | 12.74 | -32.37 | 21.35 | 10.12 | 5.6 | 0.83 | - | ||
2023/11 | 1.81 | 3.79 | -0.72 | 19.31 | 17.96 | 4.82 | 0.97 | - | ||
2023/10 | 1.74 | 38.15 | 3.64 | 17.5 | 20.3 | 5.3 | 0.88 | - | ||
2023/9 | 1.26 | -44.88 | -13.7 | 15.76 | 22.48 | 5.16 | 0.99 | - | ||
2023/8 | 2.29 | 42.37 | 20.85 | 14.49 | 27.12 | 5.49 | 0.93 | - | ||
2023/7 | 1.61 | 1.25 | -4.83 | 12.2 | 28.38 | 4.66 | 1.1 | - | ||
2023/6 | 1.59 | 9.02 | 36.47 | 10.59 | 35.56 | 4.81 | 0.76 | - | ||
2023/5 | 1.46 | -17.08 | 53.23 | 9.0 | 35.41 | 4.8 | 0.76 | 疫情趨緩及RBK挹注所致 | ||
2023/4 | 1.76 | 10.94 | 59.89 | 7.55 | 32.43 | 4.8 | 0.76 | 疫情趨緩及RBK挹注所致 | ||
2023/3 | 1.58 | 8.51 | 22.55 | 5.79 | 25.86 | 5.79 | 0.75 | - | ||
2023/2 | 1.46 | -46.74 | 5.69 | 4.2 | 27.16 | 7.22 | 0.6 | - | ||
2023/1 | 2.74 | -9.16 | 42.59 | 2.74 | 42.59 | 7.58 | 0.57 | - | ||
2022/12 | 3.02 | 65.52 | 95.1 | 19.39 | 27.14 | 6.53 | 0.68 | 新品牌RBK挹注,大型團購訂單 | ||
2022/11 | 1.82 | 8.36 | -4.4 | 16.37 | 19.47 | 4.97 | 0.89 | - | ||
2022/10 | 1.68 | 15.01 | 2.46 | 14.55 | 23.33 | 5.04 | 0.88 | - | ||
2022/9 | 1.46 | -22.81 | 44.66 | 12.86 | 26.71 | 5.05 | 0.97 | - | ||
2022/8 | 1.9 | 12.11 | 50.49 | 11.4 | 24.73 | 4.75 | 1.03 | 疫情趨緩及新品牌挹注效益所致 | ||
2022/7 | 1.69 | 45.19 | 107.83 | 9.5 | 20.61 | 3.81 | 1.28 | 去年受三級警戒疫情影響所致 | ||
2022/6 | 1.16 | 22.41 | 279.3 | 7.81 | 10.56 | 3.22 | 1.22 | 去年受三級警戒疫情影響所致 | ||
2022/5 | 0.95 | -13.48 | -1.21 | 6.65 | -1.63 | 3.34 | 1.17 | - | ||
2022/4 | 1.1 | -14.95 | -9.84 | 5.7 | -1.7 | 3.77 | 1.04 | - | ||
2022/3 | 1.29 | -6.41 | 21.37 | 4.6 | 0.46 | 4.6 | 0.65 | - | ||
2022/2 | 1.38 | -28.15 | -21.85 | 3.3 | -5.88 | 4.85 | 0.62 | - | ||
2022/1 | 1.92 | 24.27 | 10.32 | 1.92 | 10.32 | 5.38 | 0.56 | - | ||
2021/12 | 1.55 | -18.89 | -32.12 | 15.25 | -14.5 | 5.1 | 0.57 | - | ||
2021/11 | 1.91 | 16.15 | 9.54 | 13.7 | -11.92 | 4.56 | 0.64 | - | ||
2021/10 | 1.64 | 62.38 | -23.38 | 11.79 | -14.63 | 3.91 | 0.74 | - | ||
2021/9 | 1.01 | -19.7 | -6.21 | 10.15 | -13.02 | 3.08 | 1.25 | - | ||
2021/8 | 1.26 | 54.83 | -3.35 | 9.14 | -13.72 | 2.38 | 1.62 | - | ||
2021/7 | 0.81 | 164.98 | -35.42 | 7.88 | -15.17 | 2.08 | 1.85 | - | ||
2021/6 | 0.31 | -68.11 | -72.3 | 7.07 | -11.99 | 2.49 | 1.18 | 本月營收較去年同期衰退,係受疫情影響所致。 | ||
2021/5 | 0.96 | -21.04 | -26.38 | 6.76 | -2.34 | 3.25 | 0.91 | - | ||
2021/4 | 1.22 | 14.48 | 26.28 | 5.8 | 3.26 | 4.05 | 0.73 | - | ||
2021/3 | 1.07 | -39.74 | -27.0 | 4.58 | -1.52 | 4.58 | 0.63 | - | ||
2021/2 | 1.77 | 1.42 | 84.52 | 3.51 | 10.14 | 5.79 | 0.5 | 本月營業收入較去年同期增加,主係子公司業績大幅成長 | ||
2021/1 | 1.74 | -23.54 | -21.82 | 1.74 | -21.82 | 5.76 | 0.5 | - | ||
2020/12 | 2.28 | 30.89 | 39.24 | 17.84 | -6.67 | 6.17 | 0.47 | - | ||
2020/11 | 1.74 | -18.75 | -15.15 | 15.56 | -10.97 | 4.96 | 0.58 | - | ||
2020/10 | 2.14 | 98.76 | 16.97 | 13.82 | -10.41 | 4.53 | 0.64 | - | ||
2020/9 | 1.08 | -17.25 | -27.89 | 11.67 | -14.11 | 3.64 | 1.05 | - | ||
2020/8 | 1.3 | 3.46 | -3.14 | 10.59 | -12.4 | 3.67 | 1.04 | - | ||
2020/7 | 1.26 | 13.65 | -4.6 | 9.29 | -13.56 | 3.68 | 1.04 | - | ||
2020/6 | 1.11 | -15.26 | -21.07 | 8.03 | -14.82 | 3.38 | 0.93 | - | ||
2020/5 | 1.31 | 35.44 | -14.16 | 6.92 | -13.72 | 3.73 | 0.84 | - | ||
2020/4 | 0.97 | -33.82 | -33.71 | 5.61 | -13.62 | 3.38 | 0.93 | - | ||
2020/3 | 1.46 | 52.31 | -1.37 | 4.65 | -7.82 | 4.65 | 0.79 | - | ||
2020/2 | 0.96 | -57.02 | -42.07 | 3.19 | -10.49 | 4.81 | 0.76 | - | ||
2020/1 | 2.23 | 37.35 | 16.87 | 2.23 | 16.87 | 5.91 | 0.62 | - | ||
2019/12 | 1.62 | -20.92 | -6.51 | 19.1 | 12.67 | 5.51 | 0.68 | - | ||
2019/11 | 2.05 | 12.0 | 7.26 | 17.48 | 14.86 | 5.38 | 0.7 | - | ||
2019/10 | 1.83 | 22.51 | 6.8 | 15.42 | 15.95 | 4.67 | 0.8 | - | ||
2019/9 | 1.5 | 11.14 | 11.97 | 13.59 | 17.31 | 4.16 | 1.09 | - | ||
2019/8 | 1.35 | 1.9 | 8.1 | 12.09 | 18.0 | 4.07 | 1.11 | - | ||
2019/7 | 1.32 | -5.95 | 29.2 | 10.75 | 19.37 | 4.25 | 1.07 | - | ||
2019/6 | 1.4 | -7.84 | 14.86 | 9.43 | 18.11 | 4.39 | 0.87 | - | ||
2019/5 | 1.52 | 4.58 | 29.08 | 8.02 | 18.7 | 0.0 | N/A | - | ||
2019/4 | 1.46 | -1.53 | 20.03 | 6.5 | 16.51 | 0.0 | N/A | - |